Allo-HSCT for ALL (n=28)	ALL-relapse after allo-HSCT (n=7)
Age (years) (median [range])	43 [7-66]	31 [22-53]
Gender (male/female)	13 (46,4%) / 15 (53,6%)	2/13 (15,4%) -- 5/15 (33,3%)
ALL status at allo-HSCT (RC1 // RC 2)	17 (60,7%) // 11 (39,3%)	2/17 (11,8%) // 5/11 (45,5%)
Phenotype (B // T)	25 (89,3%) // 3 (10,7%)	7/25 (28%) // 0/3 (0%)
Ph/bcr-abl (negative // positive)	20 (71,4%) // 8 (28,6%)	6/20 (30%) // 1/8 (12,5%)
Donor (URD // MSD // Haplo)	16 // 11 // 1	4/16 (25%) // 2/11 (18,2%)// 1/1 (100%)
SC source (PB // BM)	25 // 3	6/25 (24%) // 1/3 (33,3%)
Conditioning type (TBI-Cy // TBF // others)	14 // 11 // 3	5/15 (33,3%) // 1/11 (9,1%) // 1/1 (100%)
Conditioning intensity (Intensive // RIC // NMA)	20 // 7 // 1	6/20 (30%) // 0/7 (0%) // 1/1 (100%)